|
|
IVERMECTIN / CANCER
IVERMECTIN SHOWS PROMISE AGAINST 28 CANCER TYPES
from the desk of Joseph Patrick Jakubal
A Mexican research team tested ivermectin against 28 different cancers ... the first study of its scale. Their 2020 paper
(Juarez et al.) suggests ivermectin could be repurposed as a cancer drug.
**Key Details:**
- Tested at 2mg/kg/day (lab conditions)
- Worked best against ovarian, breast, glioblastoma, lung, colon, uterine SCC,
liver, triple negative breast, pancreatic,
and endometrial cancers
- Least effective against osteosarcoma, gastric cancer, and melanoma
**Notable Findings:**
- Slows cancer growth by stopping cell division
- Targets cancer stem cells (which usually resist chemo)
- Boosts effectiveness of chemo drugs like docetaxel and tamoxifen
- In mice with breast cancer, it reduced tumors
- Even resistant cancers were not safe:
Lymphoma and leukemia cells
struggled to form colonies after ivermectin treatment, despite
showing
initial resistance.
**Why it matters:**
At safe human doses, ivermectin could:
1. Block cancer cell growth
2. Kill stubborn stem cells
3. Team up with existing chemo
4. Shrink tumors (seen in mice)
The study highlights ivermectin's potential as a versatile, low-cost cancer fighter.
| | | |